Supporting the path to recovery
Simple and easy to use urine drug screening dipcard and cups
Thermo Fisher Scientific, a market leader in drugs of abuse screening products, has partnered with Confirm Biosciences to provide a simple urine drug screening solution for drug courts and forensic laboratories in the United States. Detect up to 16 drugs in 5 minutes with easy-to-use urine drug screen cups!
These products are for criminal justice and forensic use only in the United States.
|Test||10 Panel/Cut-off (ng/mL)||13 Panel/Cut-off (ng/mL)||16 Panel/Cut-off (ng/mL)||One Step Fentanyl Dipcard Cut-off (ng/mL)|
|Specimen Validity Tests|
|10-Panel Package Insert||13 and 16-Panel Package Insert||Dipcard Package Insert|
The Paracelsus Software from ACT Innovations drives the entire testing process. This begins with automated scheduling of participants, randomization of tests and full chain of custody along the entire workflow from sample collection to reporting of the results within Drug Court Case Management (DCCM) systems.
How to read and interpret the results: Urine drug screen cups provide a qualitative screening positive or negative result. A more specific alternative method such as LC-MS/MS or GC-MS must be used for a confirmed analytical result.
Ensuring validity of the test: There should always be a line corresponding to the control line (C). If this is not there, the test is invalid.
Positive result: No line corresponding to the test strip (T) indicates a positive result.
Negative result: Faint line or a clear line corresponding to the test strip (T) indicates a negative result.
Limitations of the test:
- Drug Tests (Strip/Card/Device/Cup) are for professional in vitro diagnostic use, and should be only used for the qualitative detection of drugs of abuse.
- This assay provides a preliminary analytical test result only. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gass chromatography/mass spectrometry (GC/MS) has been established as the preferred confirmatory method by the National Institute on Drug Abuse (NIDA). Clinical consideration and professional judgment should be applied to any test result, particularly when preliminary positive results are indicated.
- There is a possibility that technical or procedural errors as well as other substances and factors may interfere with the test and cause false results.